Appendix 4C - 30 June 2026
Filed with ASX · · 13 pages · English
Summary by 6ix AI
The report highlights the signing of conditional sales contracts for a substantial number of livestock and the commencement of trials in collaboration with industry partners. Additionally, the company reported a decrease in cash reserves due to operating activities, while continuing to invest in research and development for its products. Terragen also announced a new national supply agreement with Nutrien Ag Solutions Australia, expanding its market reach for its biological products.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Terragen
- Terragen Secures 1st Commercial Feedlot, Mort & Co Update
- Appendix 4C - 31 March 2026
- Report finds GLP achieves 12% increase in maize silage yield
- Appendix 4D and Half Year Financial Report - 31 Dec 2025
- Terragen Raises $7.0m to Accelerate Global Commercialisation
Later from Terragen
- TGH Appendix 4E and FY26 Annual Report
- Resignation of Chief Executive Officer
- Executive Changes - Interim CEO and CFO
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Terragen into a list and get an email when it puts out news.
Follow Terragen